Hemispherx Biopharma (HEB) Moving Higher Today

While the broad markets are trading lower, Hemixpherx Biopharma (AMEX: HEB) is outperforming the market and potentially getting a bid on positive news from Sinovac Biotech (AMEX: SVA) this morning.

Earlier this morning, Sinovac announced that its H1N1 vaccine has passed expert evaluations organized by the FDA.

Traders love momo stocks like HEB and today Hemispherx BioPharma is piquing traders' interest. HEB has always been a fast moving stock that has ranged from a low of $0.25 to a high of $4.54 during the past 52-weeks, so tread lightly with this one.

Subscribe to EasyStockAlerts.com Now & Get The News Before Everyone Else!